|
KMID : 1170320170230020001
|
|
Korean Journal of Health Economics and Policy
2017 Volume.23 No. 2 p.1 ~ p.16
|
|
|
Health Economics, Health Technology Assessment, and Cost Effectiveness Analysis
|
|
Ahn Jeong-Hoon
|
|
|
Abstract
|
|
|
Korea is the first country to legislate health technology assessment system by introducing positive listing for new pharmaceuticals and new health technology assessment for new procedures and diagnostics since 2007. This review tried to clearly define the concepts related to the health technology assessment. Especially, for setting a direction of evidence based decision making system using health technology assessment in Korea, the differences between domestic system and overseas system were compared. Though the overseas system may not be always correct but improving accountability in the current Korean system seems to be a future direction considering the accountability for reasonableness (A4R) argument by Daniels (2008).
Health technology assessment is a multidisciplinary synthetic evaluation research on clinical effectiveness, safety, and cost-effectiveness of the health technology. It is not a decision making itself but a provision of helpful evidences to a rational decision making. Assessment process of scientific research and critical appraisal of the results to use in decision making process can be distinguished. Increasing transparency in these processes can improve accountability for reasonableness in Korea and hence, warrants a rational decision making.
|
|
|
KEYWORD
|
|
|
Health Technology Assessment, Cost Effectiveness Analysis, Positive Listing, Healthcare Priority Setting, Universal Healthcare Coverage
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|